Surveillance Research, American Cancer Society, Atlanta, GA, USA.
Cancer Epidemiol Biomarkers Prev. 2011 May;20(5):733-9. doi: 10.1158/1055-9965.EPI-11-0061. Epub 2011 Feb 28.
Several publications reported breast cancer incidence rates continued to decrease among white women, following the decline of about 7% from 2002 to 2003. However, none of these reports exclusively examined the trend after 2003. In this paper, we examined breast cancer incidence rates among non-Hispanic (NH) white women from 2003 to 2007 to determine whether the decrease in breast cancer incidence rates indeed persisted through 2007. In addition, we present breast cancer incidence trends for NH black and Hispanic women and postmenopausal hormone use for all three racial/ethnic groups.
Breast cancer incidence rates were calculated by race/ethnicity, age and ER status using data from the Surveillance, Epidemiology, and End Results (SEER) 12 registries for 2000 to 2007. Prevalence of postmenopausal hormone use was calculated using National Health Interview Survey data from 2000, 2005, and 2008.
From 2003 to 2007, overall breast cancer incidence rates did not change significantly among NH white women in any age group. However, rates increased (2.7% per year) for ER+ breast cancers in ages 40 to 49, and decreased for ER- breast cancers in ages 40 to 49 and 60 to 69. Similarly, overall breast cancer incidence rates did not change significantly for black and Hispanic women. Hormone use continued to decrease from 2005 to 2008 in all groups, although the decreases were smaller compared to those from 2000 to 2005.
The sharp decline in breast cancer incidence rates that occurred from 2002 to 2003 among NH white women did not continue through 2007.
Further studies are needed to better understand the recent breast cancer trends.
有几项出版物报道称,白人女性的乳腺癌发病率在 2002 年至 2003 年下降约 7%之后继续下降。然而,这些报告均未专门检查 2003 年以后的趋势。在本文中,我们检查了 2003 年至 2007 年期间非西班牙裔(NH)白人女性的乳腺癌发病率,以确定乳腺癌发病率的下降是否确实持续到 2007 年。此外,我们还介绍了 NH 黑人和西班牙裔女性的乳腺癌发病率趋势以及所有三个种族/族裔群体的绝经后激素使用情况。
使用 2000 年至 2007 年来自监测、流行病学和最终结果(SEER)12 登记处的数据,按种族/族裔、年龄和 ER 状态计算乳腺癌发病率。使用 2000 年、2005 年和 2008 年全国健康访谈调查数据计算绝经后激素使用的流行率。
在任何年龄段,2003 年至 2007 年间,NH 白人女性的总体乳腺癌发病率均无明显变化。然而,在 40 至 49 岁年龄组中,ER+乳腺癌的发病率增加(每年 2.7%),而在 40 至 49 岁和 60 至 69 岁年龄组中,ER-乳腺癌的发病率则下降。同样,黑人和西班牙裔女性的乳腺癌发病率总体上也没有明显变化。尽管与 2000 年至 2005 年相比,所有组的激素使用率从 2005 年至 2008 年继续下降,但降幅较小。
NH 白人女性乳腺癌发病率从 2002 年至 2003 年的急剧下降并未持续到 2007 年。
需要进一步研究以更好地了解最近的乳腺癌趋势。